Clinical significance of primary tumor resection in colorectal cancer patients with synchronous unresectable metastasis
- Authors
- Kim M.S.; Chung M.; Ahn J.B.; Kim C.W.; Cho M.S.; Shin S.J.; Baek S.J.; Hur H.; Min B.S.; Baik S.H.; Kim N.K.
- Issue Date
- 2014
- Publisher
- John Wiley & Sons Inc.
- Keywords
- chemotherapy; colorectal neoplasm; primary tumor resection; synchronous unresectable metastasis
- Citation
- Journal of Surgical Oncology, v.110, no.2, pp 214 - 221
- Pages
- 8
- Indexed
- SCI
SCIE
SCOPUS
- Journal Title
- Journal of Surgical Oncology
- Volume
- 110
- Number
- 2
- Start Page
- 214
- End Page
- 221
- URI
- https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/9963
- DOI
- 10.1002/jso.23607
- ISSN
- 0022-4790
1096-9098
- Abstract
- Background The aim of this study was to compare the outcomes in colorectal cancer (CRC) patients with synchronous unresectable metastases who received either primary tumor resection (PTR) or chemotherapy as the first treatment and to investigate the clinical course of asymptomatic patients who received chemotherapy as the first treatment. Methods We retrospectively analyzed 324 CRC patients with synchronous unresectable metastases. Overall survival (OS) was analyzed for the two groups (upfront PTR group [n = 72] vs. upfront chemotherapy group [n = 252]). Surgical morbidity and mortality were recorded. In the asymptomatic patients who received upfront chemotherapy, the incidences of primary tumor-related complications were analyzed. Results In patients who underwent PTR as the first treatment, the median OS period was superior to those who received upfront chemotherapy (17.2 vs. 13.6 months, P = 0.002). In the PTR group, surgical morbidity and mortality were 11.6% and 1.9%, respectively. Of the 252 asymptomatic patients, the incidence of primary tumor-related complications was 35%. Emergent surgery was ultimately done in 14% of the 252 patients. Conclusion CRC patients with synchronous unresectable metastases who underwent PTR followed by chemotherapy had significantly longer survival times compared to patients who received chemotherapy as the first treatment. © 2014 Wiley Periodicals, Inc.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 2. Clinical Science > Department of Colon and Rectal Surgery > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/9963)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.